Filling the Void in Drug Delivery

Eupraxia is a clinical stage biotechnology company focused on the development of locally-delivered, extended-release alternatives to new and existing pharmaceuticals. Each of Eupraxia’s product candidates are designed to achieve improved patient benefit by providing longer term activity than currently available treatments, combined with precisely targeted local delivery. This offers the dual potential of providing long-lasting treatment while minimizing safety complications in target and non-target tissues.